Welcome Valarie Mitchell, FNP to Our Corinth Campus

Posted by & filed under Uncategorized.

We are so thrilled to announce a new addition to our Corinth Team! Valarie Mitchell, FNP will be joining our West Cancer Center family on March 8, 2021 She is a Gynecologic Nurse Practitioner with over 20 years of experience in women’s health. With the addition of a Gynecologic, our Corinth Campus is able to… Read more »

Patient Care Support

Posted by & filed under Uncategorized.

We are with you every step of the way. As a West Cancer Center patient, you and your loved ones have a unique benefit of comprehensive and individualized support throughout your journey here. We have a variety of services specifically dedicated to helping patients identify potential barriers that may prevent them from receiving the best... Read more »

119 Publications in Distinguished Journals in 2020

Posted by & filed under Uncategorized.

Trust your cancer care to our providers at West Cancer Center & Research Institute who authored 119 publications in distinguished medical journals in 2020 alone. We are standing behind our name and respected by leaders in oncology care. Matthew Ballo: VanderWalde NA, Martin MY, Kocak M, Morningstar C, Deal AM, Nyrop KA, Farmer M, Ballo… Read more »

West welcomes 3 distinguished physicians as partners

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute welcomes three distinguished physicians as partners of the cancer center   West Cancer Center & Research Institute is governed by a physician partnership to ensure care for cancer patients is clinically superior with the latest technology and research. Matthew Ballo, MD, FACR, Richard Fine, MD, FACS and Eric Wiedower,… Read more »

West Physician, Dr. Michael Martin, Recognized by International Journal of Molecular Sciences for Highest Impact of Publication

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute’s Michael G. Martin, MD, has been recognized by the distinguished International Journal of Molecular Sciences for a publication of high impact based on views and downloads.   West Cancer Center & Research Institute is home to more than 100 oncology/hematology specialists with 1000+ publications in numerous esteemed medical journals…. Read more »

2021 West Oncology Conference

Posted by & filed under Uncategorized.

The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »

2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents

Posted by & filed under Uncategorized.

2020 Top Stories in Advanced Melanoma: Drastic Improvement in Melanoma Mortality With Novel Agents   Written by Ari VanderWalde MD, MPH, FACP   Despite a plethora of interesting findings and results of novel clinical trials in melanoma in 2020, I believe the most important story of the year was actually a small, easy-to-overlook, 3-page report in the American… Read more »

Psychology

Posted by & filed under Uncategorized.

Our psychologist provides counseling and therapies to help you and your family adjust to the diagnosis of cancer, reduce stress, and improve your emotional well-being throughout the continuum of care from initial diagnosis, during treatment, and beyond survivorship. When emotional distress begins to interfere with quality of life, our team can provide a range of... Read more »

Dr. Grothey on the Role of Precision Medicine in CRC

Posted by & filed under Uncategorized.

Axel Grothey, MD, medical oncologist and our Director of Gastrointestinal Cancer Research, discusses the role of precision medicine in colorectal cancer (CRC) with OncLive. Grothey says, “With the rise of molecular profiling, the field of CRC has shifted away from a one-size-fits-all approach and entered an era of precision medicine. Notably, molecular profiling guides the… Read more »

Dr. Lee Schwartzberg on HER2– HR+ Breast Cancer: Tesetaxel & Capecitabine

Posted by & filed under Uncategorized.

Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »